标题
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
作者
关键词
Ketamine, Esketamine, Major depressive disorder, Interventional psychiatry, Pain
出版物
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 434, Issue -, Pages 120152
出版商
Elsevier BV
发表日期
2022-01-14
DOI
10.1016/j.jns.2022.120152
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms
- (2021) Mingzheng Wu et al. BIOLOGICAL PSYCHIATRY
- Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
- (2021) Plinio C. Casarotto et al. CELL
- Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
- (2021) Eric P. McMullen et al. ADVANCES IN THERAPY
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
- (2021) Yanling Zhou et al. Journal of Neuroinflammation
- Microglial NMDA receptors drive pro‐inflammatory responses via PARP‐1/TRMP2 signaling
- (2020) Prajwal Raghunatha et al. GLIA
- Ascending‐Dose Study of Controlled‐Release Ketamine Tablets in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability
- (2020) Paul Glue et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The potential role of the HCN1 ion channel and BDNF-mTOR signaling pathways and synaptic transmission in the alleviation of PTSD
- (2020) Lianghui Ni et al. Translational Psychiatry
- A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression
- (2020) Mikael Tiger et al. Translational Psychiatry
- Intranasal esketamine: A novel drug for treatment-resistant depression
- (2020) Farah Khorassani et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression
- (2020) Yan-Ling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
- (2020) Paulo R. Shiroma et al. Translational Psychiatry
- Intranasal ketamine for acute pain management in children: A systematic review and meta-analysis
- (2020) Lucas Oliveira J. e Silva et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases
- (2020) Lauren M. Behlke et al. CNS DRUGS
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults
- (2020) Rafae Wathra et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials
- (2020) Liwei Pang et al. Frontiers in Pharmacology
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine Infusions for Chronic Pain
- (2019) Vwaire Orhurhu et al. ANESTHESIA AND ANALGESIA
- Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
- (2019) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis
- (2019) J. Mark Riddell et al. BRITISH JOURNAL OF ANAESTHESIA
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- A neural circuit for comorbid depressive symptoms in chronic pain
- (2019) Wenjie Zhou et al. NATURE NEUROSCIENCE
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain
- (2018) Marie T. Fallon et al. JAMA Oncology
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial
- (2018) G.A. Mashour et al. BRITISH JOURNAL OF ANAESTHESIA
- Intraoperative S-ketamine for the reduction of opioid consumption and pain one year after spine surgery: A randomized clinical trial of opioid dependent patients
- (2018) R V Nielsen et al. EUROPEAN JOURNAL OF PAIN
- Untangling the complexity of opioid receptor function
- (2018) Rita J. Valentino et al. NEUROPSYCHOPHARMACOLOGY
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- Case Report: Ketamine for Pain and Depression in Advanced Cancer
- (2018) Jessica Sexton et al. JOURNAL OF PALLIATIVE MEDICINE
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children
- (2018) Theresa M. Frey et al. JAMA Pediatrics
- Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
- (2017) Minkyung Park et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice
- (2017) T.H. Pham et al. NEUROPHARMACOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Recurrence of depressive disorders after interferon-induced depression
- (2017) W-C Chiu et al. Translational Psychiatry
- Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
- (2017) D D Kiraly et al. Translational Psychiatry
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- A REVIEW OF KETAMINE ABUSE AND DIVERSION
- (2016) Sean Sassano-Higgins et al. DEPRESSION AND ANXIETY
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Neuropeptide S modulates the amygdaloidal HCN activities ( I h ) in rats: Implication in chronic pain
- (2016) Shuzhuo Zhang et al. NEUROPHARMACOLOGY
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial
- (2016) Eric J. Lenze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine
- (2016) K. Zhang et al. Science Signaling
- What do monoamines do in pain modulation?
- (2016) Kirsty Bannister et al. Current Opinion in Supportive and Palliative Care
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
- (2015) Jian-jun Yang et al. BIOLOGICAL PSYCHIATRY
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- Ketamine and phencyclidine: the good, the bad and the unexpected
- (2015) D Lodge et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials
- (2015) Li Wang et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery
- (2015) Min Jiang et al. Journal of Anesthesia
- Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists
- (2015) Brandon R. Selfridge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
- (2015) Florian Freudenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
- (2015) Y.-D. Hu et al. PSYCHOLOGICAL MEDICINE
- Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
- (2015) Nicolas D. Iadarola et al. Therapeutic Advances in Chronic Disease
- A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain
- (2014) E. D. MCNICOL et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- A Word to the Wise About Ketamine
- (2014) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
- (2014) Dawn F Ionescu et al. BIPOLAR DISORDERS
- Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling
- (2014) Anna Dellarole et al. BRAIN BEHAVIOR AND IMMUNITY
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
- (2014) Jordan F. Karp et al. JOURNAL OF CLINICAL PSYCHIATRY
- Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
- (2014) Kenichi Fukumoto et al. PSYCHOPHARMACOLOGY
- A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
- (2014) H Yamanaka et al. Translational Psychiatry
- Intranasal Ketamine for Analgesia in the Emergency Department: A Prospective Observational Series
- (2013) Gary Andolfatto et al. ACADEMIC EMERGENCY MEDICINE
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Inhibition of HCN channels within the periaqueductal gray attenuates neuropathic pain in rats.
- (2013) Lu Du et al. BEHAVIORAL NEUROSCIENCE
- The role of HCN channels within the periaqueductal gray in neuropathic pain
- (2013) Lu Du et al. BRAIN RESEARCH
- Ketamine and Peripheral Inflammation
- (2013) Marc De Kock et al. CNS Neuroscience & Therapeutics
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Neurophysiology of HCN channels: From cellular functions to multiple regulations
- (2013) Chao He et al. PROGRESS IN NEUROBIOLOGY
- Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus
- (2013) CHUN YANG et al. Experimental and Therapeutic Medicine
- Estimation of the Contribution of Norketamine to Ketamine-induced Acute Pain Relief and Neurocognitive Impairment in Healthy Volunteers
- (2012) Erik Olofsen et al. ANESTHESIOLOGY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Enhancement of Dorsal Hippocampal Activity by Knockdown of HCN1 Channels Leads to Anxiolytic- and Antidepressant-like Behaviors
- (2012) Chung Sub Kim et al. NEURON
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
- (2012) Christian A. von Hehn et al. NEURON
- The neuropathic component in persistent postsurgical pain: A systematic literature review
- (2012) Simon Haroutiunian et al. PAIN
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
- (2011) Ream Al-Hasani et al. ANESTHESIOLOGY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- A systematic review of intravenous ketamine for postoperative analgesia
- (2011) Kevin Laskowski et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo-controlled trial
- (2011) Ingeborg Noppers et al. EUROPEAN JOURNAL OF PAIN
- Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain
- (2011) Xiao-Peng Mei et al. Journal of Neuroinflammation
- Microglial Ca2+-Activated K+ Channels Are Possible Molecular Targets for the Analgesic Effects of S-Ketamine on Neuropathic Pain
- (2011) Y. Hayashi et al. JOURNAL OF NEUROSCIENCE
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function
- (2011) Chih-Chieh Wang et al. NEURON
- Ketamine-associated lower urinary tract destruction: a new radiological challenge
- (2010) K. Mason et al. CLINICAL RADIOLOGY
- Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
- (2010) Simone Portmann et al. JOURNAL OF CHROMATOGRAPHY A
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Spinal hyperpolarization-activated cyclic nucleotide-gated cation channels at primary afferent terminals contribute to chronic pain
- (2010) Keiko Takasu et al. PAIN
- Social Interaction Prevents the Development of Depressive-Like Behavior Post Nerve Injury in Mice: A Potential Role for Oxytocin
- (2010) Greg J. Norman et al. PSYCHOSOMATIC MEDICINE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Role of interleukin-1β during pain and inflammation
- (2009) Ke Ren et al. BRAIN RESEARCH REVIEWS
- Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain
- (2009) Chui Chong et al. CLINICAL DRUG INVESTIGATION
- Ketamine-associated bladder dysfunction
- (2009) Tsung-Hsun Tsai et al. INTERNATIONAL JOURNAL OF UROLOGY
- HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
- (2009) X. Chen et al. JOURNAL OF NEUROSCIENCE
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
- (2009) Alban Latremoliere et al. JOURNAL OF PAIN
- HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K+ channels
- (2009) Meena S George et al. NATURE NEUROSCIENCE
- Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study
- (2009) Robert J. Schwartzman et al. PAIN
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Chronic post-surgical pain: 10 years on
- (2008) W.A. Macrae BRITISH JOURNAL OF ANAESTHESIA
- Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function
- (2008) Yejun Zhao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder
- (2008) M J Lan et al. MOLECULAR PSYCHIATRY
- On the relationship between emotion and cognition
- (2008) Luiz Pessoa NATURE REVIEWS NEUROSCIENCE
- Attentional bias to incentive stimuli in frequent ketamine users
- (2008) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started